(S009) In Silico Trial of MR-Guided Mid-Treatment Adaptive Planning for Hypofractionated Stereotactic Radiotherapy in Centrally Located Thoracic Tumors

International Journal of Radiation Oncology, Biology, Physics, Volume 98, Issue 2, Supplement, 2017 Jun 1 | Henke, Lauren E., MD; Kashani, Rojano, PhD; Przybysz, Daniel, MD;...
Background Hypofractionated (>5fx) stereotactic radiotherapy (HSRT) may allow for biologically equivalent dose to tumor with a lower risk of organ at risk (OARacrnm1) toxicity in centrally located thoracic tumors (CTTacrnm1). Adaptive planning ...

http://ift.tt/2rFWVHB